Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:INTS

Intensity Therapeutics (INTS) Stock Price, News & Analysis

Intensity Therapeutics logo

About Intensity Therapeutics Stock (NASDAQ:INTS)

Advanced Chart

Key Stats

Today's Range
$2.36
$2.79
50-Day Range
N/A
52-Week Range
$0.26
$5.09
Volume
73,559 shs
Average Volume
473,117 shs
Market Capitalization
$8.40 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.75
Consensus Rating
Moderate Buy

Company Overview

Intensity Therapeutics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
50th Percentile Overall Score

INTS MarketRank™: 

Intensity Therapeutics scored higher than 50% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Intensity Therapeutics has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Intensity Therapeutics has only been the subject of 1 research reports in the past 90 days.

  • Read more about Intensity Therapeutics' stock forecast and price target.
  • Earnings Growth

    Earnings for Intensity Therapeutics are expected to grow in the coming year, from ($1.18) to ($1.00) per share.

  • Price to Book Value per Share Ratio

    Intensity Therapeutics has a P/B Ratio of 1.76. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    2.94% of the float of Intensity Therapeutics has been sold short.
  • Short Interest Ratio / Days to Cover

    Intensity Therapeutics has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Intensity Therapeutics has recently decreased by 37.42%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Intensity Therapeutics does not currently pay a dividend.

  • Dividend Growth

    Intensity Therapeutics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.94% of the float of Intensity Therapeutics has been sold short.
  • Short Interest Ratio / Days to Cover

    Intensity Therapeutics has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Intensity Therapeutics has recently decreased by 37.42%, indicating that investor sentiment is improving significantly.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Intensity Therapeutics this week, compared to 0 articles on an average week.
  • Search Interest

    7 people have searched for INTS on MarketBeat in the last 30 days. This is an increase of 600% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Intensity Therapeutics insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    17.10% of the stock of Intensity Therapeutics is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 3.74% of the stock of Intensity Therapeutics is held by institutions.

  • Read more about Intensity Therapeutics' insider trading history.
Receive INTS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Intensity Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

INTS Stock News Headlines

Forget Nvidia, This “Ghost Town” Company Holds the Key to the AI Boom
Cold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to investigate this crazy Cold War story… Because it could hold the key to the entire $100 trillion AI boom. It involves an American ghost town with just 30 people… And a new twist to the AI boom that could make a lot of people rich.
See More Headlines

INTS Stock Analysis - Frequently Asked Questions

Intensity Therapeutics Inc. (NASDAQ:INTS) released its quarterly earnings data on Tuesday, May, 13th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by $0.01.

Intensity Therapeutics (INTS) raised $20 million in an initial public offering on Friday, June 30th 2023. The company issued 3,900,000 shares at $5.00 per share.

Based on aggregate information from My MarketBeat watchlists, some other companies that Intensity Therapeutics investors own include Amgen (AMGN), Costco Wholesale (COST), Cisco Systems (CSCO), Honeywell International (HON), Intel (INTC), Intuitive Surgical (ISRG) and Mondelez International (MDLZ).

Company Calendar

Last Earnings
5/13/2025
Today
7/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED-BIOMED/GENE
Sub-Industry
N/A
Current Symbol
NASDAQ:INTS
CIK
1567264
Fax
N/A
Employees
2,021
Year Founded
N/A

Price Target and Rating

High Price Target
$8.50
Low Price Target
$5.00
Potential Upside/Downside
+1,914.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.07)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$16.27 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-527.85%
Return on Assets
-276.29%

Debt

Debt-to-Equity Ratio
0.31
Current Ratio
0.63
Quick Ratio
0.63

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.19 per share
Price / Book
1.76

Miscellaneous

Outstanding Shares
25,070,000
Free Float
20,786,000
Market Cap
$8.40 million
Optionable
Not Optionable
Beta
3.27
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:INTS) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners